These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38108824)

  • 1. The financial burden after liver transplantation is significant among commercially insured adults: A large US National Cohort.
    Lieber SR; Jiang Y; Jones AR; Gowda P; Ufere NN; Patel MS; Gurley T; Noriega Ramirez A; Ngo VM; Olumesi MC; Trudeau RE; Marrero J; Craddock Lee SJ; Mufti A; Singal AG; VanWagner LB
    Liver Transpl; 2023 Dec; ():. PubMed ID: 38108824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden.
    Lieber SR; Jones AR; Jiang Y; Gowda P; Patel M; Lippe B; Shenoy A; Evon DM; Gurley T; Ngo V; Olumesi M; Trudeau RE; Noriega Ramirez A; Jordan-Genco L; Mufti A; Lee SC; Singal AG; VanWagner LB
    Liver Transpl; 2024 Jun; ():. PubMed ID: 38713020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial burden in a US cohort of patients with HCC.
    Desai R; Jiang Y; VanWagner LB; Singal AG; Lieber SR
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38829203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US.
    Miloh T; Goldstein A; Howard R; Mogul DB; Marden JR; Anderson A; Gaburo K; Kirson N; Rosenthal P
    Liver Transpl; 2023 Jul; 29(7):735-744. PubMed ID: 36747344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.
    McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI
    J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals.
    Patel MJ; Jones A; Jiang Y; Gowda P; VanWagner LB; Cotter TG; Seif El Dahan K; Louissaint J; Patel M; Rich NE; Singal AG; Lieber SR
    Aliment Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38863242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 11. Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA.
    Hagiwara M; Divino V; Munnangi S; Delegge M; Park S; Marins EG; Ren K; Strange C
    J Comp Eff Res; 2024 Jun; 13(6):e230186. PubMed ID: 38696696
    [No Abstract]   [Full Text] [Related]  

  • 12. Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population.
    Mattingly TJ; Pandit NS; Onukwugha E
    Infect Dis Ther; 2019 Jun; 8(2):219-228. PubMed ID: 30825134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost sharing for oral lenvatinib among commercially insured patients.
    Liang MI; Chen L; Aviki EM; Wright JD
    Am J Manag Care; 2024 Mar; 30(3):114-117. PubMed ID: 38457819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The financial burden of transplantation: a single-center survey of liver and kidney transplant recipients.
    Rodrigue JR; Reed AI; Nelson DR; Jamieson I; Kaplan B; Howard RJ
    Transplantation; 2007 Aug; 84(3):295-300. PubMed ID: 17700152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China.
    Yong M; Xianjun X; Jinghu L; Yunyun F
    Aust Health Rev; 2018 Feb; 42(1):39-44. PubMed ID: 28263706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
    Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA
    J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
    Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
    J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
    Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.